Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 7—July 2019
Synopsis

Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear–Negative Drug-Resistant Tuberculosis, China

Fei Huang, Susan van den Hof, Yan Qu, You Li, Hui ZhangComments to Author , Lixia Wang, Miaomiao Sun, Wei Lu, Shuangyi Hou, Tianhua Zhang, Shitong Huan, Daniel P. Chin, and Frank Cobelens
Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, China (F. Huang, Y. Qu, Y. Li, H. Zhang, L. Wang); The Royal Netherlands Tuberculosis Foundation, The Hague, the Netherlands (S. van den Hof); Academic Medical Center, Amsterdam, the Netherlands (S. van den Hof, F. Cobelens); PATH, Beijing (M. Sun); Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, China (W. Lu); Hubei Provincial Center for Disease Control and Prevention, Hubei, China (S. Hou); Shaanxi Provincial Institute for Tuberculosis Control and Prevention, Shaanxi, China (T. Zhang); Bill & Melinda Gates Foundation, Beijing (S. Huan); Bill & Melinda Gates Foundation, Seattle, Washington, USA (D.P. Chin)

Main Article

Table 3

Patient characteristics associated with culture positivity for smear-negative TB patients, Yichang and Zhenjiang prefectures, China*

Characteristic Yichang
Zhenjiang
Culture, no. (%)
 Unadjusted OR (95% CI) Adjusted OR (95% CI) Culture, no. (%)
 Unadjusted OR (95% CI) Adjusted OR (95% CI)
Negative Positive Negative Positive
Age, y
0–39 401 102 (20.3) Referent Referent 166 12 (6.7) Referent Referent
40–59 565 129 (18.6) 0.9 (0.7–1.2) 0.9 (0.7–1.2) 215 14 (6.1) 0.9 (0.4–2.0) 1.0 (0.4–2.3)
>60
 507
 127 (20.0)
 1.0 (0.7–1.3)
 1.0 (0.8–1.4)
316
 26 (7.6)
 1.1 (0.6–2.3)
 1.3 (0.6–2.8)
Sex
M 1,001 260 (20.6) Referent Referent 514 38 (6.9) Referent Referent
F
 472
 98 (17.2)
 0.8 (0.6–1.0)
 0.8 (0.6–1.0)
183
 14 (7.1)
 1.0 (0.6–2.0)
 1.1 (0.6–2.0)
TB treatment history
New 1,455 325 (18.3) Referent Referent 604 42 (6.5) Referent Referent
Retreatment
 18
 33 (64.7)
 8.2 (4.6–14.8)
 7.7 (4.2–14.1)
93
 10 (9.7)
 1.5 (0.8–3.2)
 1.6 (0.8–3.3)
Disease severity
Not severe 1,313 284 (17.8) Referent Referent 645 48 (6.9) Referent Referent
Severe
 160
 74 (31.6)
 2.1 (1.6–2.9)
 2.1 (1.5–2.9)
52
 4 (7.1)
 1.0 (0.4–3.0)
 1.0 (0.3–2.9)
Citizenship
Local 1,326 267 (16.8) Referent Referent 523 34 (6.1) Referent Referent
Migrant
 147
 91 (38.2)
 3.1 (2.3–4.1)
 3.1 (2.2–4.1)
174
 18 (9.4)
 1.6 (0.9–2.9)
 1.8 (0.9–3.3)
Total 1,473 358 (19.6) NA NA 697 52 (6.9) NA NA

*Values in bold indicate a statistically significant association (p<0.05). OR, odds ratio; NA, not applicable; TB, tuberculosis.

Main Article

Page created: June 17, 2019
Page updated: June 17, 2019
Page reviewed: June 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external